Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden

FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported the results of pembrolizumab (Keytruda), a PD-1 immune checkpoint inhibitor, with or without

July 15, 2023

Obesity drug from Roche succeeds in early test, sending company shares up

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending

May 16, 2024

Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

A new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.